We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Handling Procedures Affect Interleukin 6 Levels in Samples

By LabMedica International staff writers
Posted on 26 Oct 2019
Interleukin‐6 (IL‐6), a pleiotropic cytokine, is released by a variety of cell types such as immune cells, endothelial cells, and even certain tumor cells. More...
It is a classic proinflammation cytokine which exhibits broad‐ranging biological activities by involved in the intricate cellular communication.

Pre‐analytical variables for the test include blood collection tubes, specimen storage temperature and time, plasma or serum separation, and pretreatment steps. Studies have shown pre‐analytical handling steps can influence sample quality and analytical results. The fact that the half‐life of IL‐6 is short, degradation and production may occur simultaneously during storage under unseparated condition.

Medical Laboratory Scientists at the Southern Medical University (Guangzhou, China) collected EDTA plasma and serum samples from 45 healthy individuals. The participants were divided into three groups to perform different handling procedures. Different centrifugal timing, storage temperature, and time were executed on the samples. All samples were centrifuged at 1760 ×g for 15 minutes, but centrifugal timing selection was different in three groups. Serum and plasma IL‐6 levels were assayed through the electrochemiluminescence (ECLIA) method on Cobas e 601 analyzer. The changed trends of IL‐6 levels were analyzed.

The team reported that at baseline, while the paired plasma and serum IL‐6 values had a good correlation, the plasma levels were higher than serum. In general, the unseparated EDTA plasma kept steady with time. With the increase in storage temperature and time, a more pronounced rise in unseparated serum IL‐6 was observed. Nevertheless, the samples in the group, which was centrifuged and separated immediately kept stable after a different temperature and longtime storage.

The authors concluded that factors that affect changes in cytokine levels are various and incorrect sample handling procedures may result in false results. In general, unseparated EDTA plasma can keep IL‐6 steady for up to 24 hours. In not refrigerated conditions, unseparated serum is recommended to measure IL‐6 as soon as possible. Otherwise, the serum separation should be done. The study was published in the September 2019 issue of the Journal of Clinical Laboratory Analysis.

Related Links:
Southern Medical University


New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Online QC Software
Acusera 24•7
New
Fully-auto Specific Protein (Nephelometry) Analyzer
PA480
Hematology Consumables
Bioblood Devices
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image:Schematic illustration of plasmonic microarray–based KRAS mutation detection from colorectal cancer patients. (Lee, J.Y., Mun, C.W., Kim, E.R. et al. npj Precision Oncology, 2026. https://doi.org/10.1038/s41698-026-01452-8)

Blood and Urine Liquid Biopsy Detects Early Colorectal Cancer Mutations

Early-stage colorectal cancer is difficult to assess noninvasively because tumor-derived mutations occur at extremely low levels in blood and urine, straining the sensitivity, cost, and turnaround time... Read more

Hematology

view channel
Image Credit: Shutterstock

New Biomarkers Predict Resistance to Targeted Therapy in Rare Blood Cancer

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive leukemia with limited treatment options and a poor prognosis. Although tagraxofusp is the first approved targeted therapy for... Read more

Industry

view channel
Photo courtesy of Natera

Natera’s Signatera Earns IVDR Certification for Solid Tumor MRD Testing

Natera’s Signatera has received certification as a Class C device under the European Union’s In Vitro Diagnostic Regulation (IVDR), becoming the first personalized MRD test for solid tumors to achieve... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.